-
Most Commented
- Cubadebate opens its new Web page in English | 20
- Mandela is dead: Why hide the truth about Apartheid? | 11
- El Paso Diary: The Battle Over the Solo Fax | 10
- President Hugo Chavez's address to the People of Venezuela | 10
- Free the Five is heard at Left Forum | 6
- May every citizen be a constituent | 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea | 6
- The Unsustainable Position of the Empire | 5
- U.S. government promoting Internet aggression against Cuba | 5
- NATO’s Genocidal Role | 4
- The Fiftieth Anniversary Parade | 4
- El Paso Diary: The Tip of the Iceberg | 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of vaccine
News »
Cinicial trials of Soberana-Pediatria in children 3-11 years of age begin
The study of the Cuban anti-COVID candidate vaccine will include 350 children and adolescents, 50 in Phase I and 300 in Phase II, conducted in an overlapping and gradual process, in strict compliance with protocols and best practices. Following verification of the candidate’s safety in a group of adolescents aged 12 to 18, clinical trials of Soberana-Pediatria continue with the inclusion of a second group of volunteers in the three to 11 age group, Yury Valdes Balbin, assistant director of the Finlay Vaccine Institute, reported.
News »
Antigen testing of suspected COVID-19 patients in Havana
Given the complex epidemiological situation in the capital, recently experiencing growing numbers of new COVID-19 cases, the city’s neighborhood polyclinics and hospitals have begun administering antigen tests for the virus to patients with symptoms indicative of a possible infection. According to information presented in a meeting of the Provincial Defense Council, every facility of this type now has on hand the resources needed to provide the test.
News »
Cuba will vaccinate its entire population against COVID-19 in 2021
The Party and government’s strong political will has made this possible, along with the impressive work of our scientists who have again reiterated that Cuba will be among the first countries in the world to vaccinate its entire population in 2021, despite the tightening of the U.S. blockade of the island over the past 12 months, stated Dr. Eduardo Martínez Díaz, president of the BioCubaFarma state pharmaceutical enterprise group, on his Twitter account.
News »
Cuba prepares to protect Covid-19 convalescents
Cuba is currently advancing in the development of a clinical trial in patients convalescing from Covid-19, who had a mild clinical record or were asymptomatic. ‘The clinical development program of Soberana 01 (vaccine candidate against Covid-19) includes the assessment in convalescents, a population that has not been in the target of vaccines,’ highlighted on Twitter the director of Research of the Finlay Institute of Vaccines, Dagmar Garcia.
News »
Cuba readies 100 million doses of anti-COVID vaccine
The general director of the Finlay Vaccine Institute, Vicente Vérez Bencomo, announced, at a press conference with accredited foreign agencies in attendance, that Cuba is creating capacity to produce 100 million doses of the Soberana 02 injectable vaccine against COVID-19. He reiterated that the objective is to satisfy the needs of the country and also those of other nations interested in acquiring the vaccine.
News »
Vaccines and Sovereignty (III) The Antigen of Cuban Vaccines Against Covid-19
The development of a vaccine today requires the existence of today’s conditions for this kind of research. It must begin by looking at the scientific literature for antecedents and ways of doing things that can lead to the implementation of more and more exquisite laboratory procedures and rigorous tests. In our case and for the above reasons, a firm base for the research was already established when the COVID 19 emergency arose.
News »
Soberana 02 clinical trials expanded
Expanded phase II B clinical trials of Cuba’s anti-COVID-19 candidate vaccine Soberana 02 with volunteers between 19 and 80 years of age, began at the 19 de Abril and No.1 Polyclinics, in the Havana municipalities of Plaza de la Revolución and La Lisa, respectively. For the purpose of evaluating reactions, safety and immunogenicity of the candidate, created by the Finlay Vaccine Institute, volunteers will receive two doses of the drug, administered intramuscularly.
News »
Vaccines and Sovereignty II: What are Vaccines?
The molecules of an invading biological entity that are identified and are accessible to the human immune system are often referred to as “antigens”. They are usually expressed in the outermost parts of the nanoscopic carrier and are a necessary part of its composition. They are the same when found in a virus, in a fungus, in a bacterium, or in the cells of an organ from another being transplanted into our body.
News »
Abdala vaccine clinical trial is going well in Cuba
Abdala vaccine clinical trial is going well in CubaSantiago de Cuba, Jan 9 (Prensa Latina) The clinical trial of the vaccine candidate Abdala, one of the four underway in Cuba, is going well today at the Saturnino Lora Hospital in this eastern city, where it has been taking place for the last month. Dr. Rafael Suárez, director of the healthcare center, reported that the intramuscular application of the preparation for immunization against Covid-19 has hardly presented adverse reactions, mainly associated with discomfort in the area of the puncture.
News »
Cuba and Iran sign an agreement on Sovereign vaccine 02
Cuban Finlay Vaccines Institute and the Pasteur Institute of Iran signed a collaboration agreement here to complement the clinical evidence of the anti-Covid-19 vaccine candidate from the Caribbean island, Soberana02. In its official Twitter account, the Cuban entity explained that ‘this synergy will allow faster progress in immunization against the SARS-CoV-2 virus in both countries.’